Antineutrophil cytoplasmic antibodies in patients with early rheumatoid arthritis: An early marker of progressive erosive disease

Arthritis and Rheumatism

Volumn 43, Issue 6, 2000, Pages 1371-1377

  Mustila, Anu ^a,c   Paimela, Leena ^b   Leirisalo Repo, Marjatta ^b   Huhtala, Heini ^c   Miettinen, Ari ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIGEN RECOGNITION; ARTICLE; DISEASE ACTIVITY; ENZYME IMMUNOASSAY; ENZYME SPECIFICITY; FEMALE; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; RHEUMATOID ARTHRITIS;

ADOLESCENT; ADULT; AGED; ANTIBODIES; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, ANTINUCLEAR; ARTHRITIS, RHEUMATOID; ARTHROGRAPHY; BIOLOGICAL MARKERS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KERATINS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROGNOSIS;

EID: 0034125855     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200006)43:6<1371::AID-ANR22>3.0.CO;2-R     Document Type: Article

References (47)

1. Van der Woude FJ, Lobatto S, Permin H, van der Giessen M, Rasmussen N, Wiik A, et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985;i:425-4.
2. Gross WL, Lüdemann G, Kiefer G, Lehmann H. Anticytoplasmic antibodies in Wegener's granulomatosis [letter]. Lancet 1986;i:806.
3. Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for mycloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988;318:1651-7.
4. Nölle B, Specks U, Lüdemann J, Rohbach MS, DeRemee RA, Gross WL. Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener's granulomatosis. Ann Intern Med 1989;111:28-40.
5. Jennette JC, Wilkman AS, Falk RJ. Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. Am J Pathol 1989;135:921-30.
6. Cohen Tervaert JW, Goldschmeding R, Elema JD, van der Giessen M, Huitema MG, van der Hem GK, et al. Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis. Kidney Int 1990;37:799-806.
7. Cohen Tervaert JW, Limburg PC, Elema JD, Huitema MG, Horst G, The TH, et al. Detection of autoantibodies against myeloid lysosomal enzymes: a useful adjunct to classification of patients with biopsy-proven necrotizing arteritis. Am J Med 1991;91:59-66.
8. Cohen Tervaert JW, Huitema MG, Hené RJ, Sluiter WJ, The TH, van der Hem GK, et al. Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 1990;336:709-11.
9. Goldschmeding R, van der Shoot CF, ten Bokkel Huinink D, Hack CE, van der Ende ME, Kallenberg CGM, et al. Wegener's granulomatosis autoantibodies identify a novel diisopropyl-fluorophosphate-binding protein in the lysosomes of normal human neutrophils. J Clin Invest 1989;84:1577-87.
10. Niles JL, McCluskey RT, Ahmad MF, Arnaout MA. Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase. Blood 1989;74:1888-93.
11. Lüdemann J, Utecht B, Gross WL. Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme. J Exp Med 1990;171:357-62.
12. Jennette JC, Hoidal JH, Falk RJ. Specificity of anti-neutrophil cytoplasmic antibodies tor proteinase 3. Blood 1990;78:2263-4.
13. Cohen Tervaert JW, Goldschmeding R, Elema JD, Limburg PC, van der Giessen M, Huitema MG, et al. Association of autoantibodies to myeloperoxidase with different forms of vasculitis. Arthritis Rheum 1990;33:1264-72.
14. Snook JA, Chapman RW, Fleming K, Jewell DP. Anti-neutrophil nuclear antibody in ulcerative colitis. Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol 1989;76:30-3.
15. Saxon A, Shanahan F, Landers C, Ganz T, Targan S. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 1990;86:202-10.
16. Wiik A, Jensen E, Friis J. Granulocyte-specific antinuclear factors in synovial fluids and sera from patients with rheumatoid arthritis. Ann Rheum Dis 1974;33:515-22.
17. Savige JA, Gallichio MC, Stockman A, Cunningham TJ, Rowley MJ, Georgiou T, et al. Antineutrophil cytoplasm antibodies in rheumatoid arthritis. Clin Exp Immunol 1991;86:92-8.
18. Braun MG, Csernok E, Schmitt WH, Flesch BK, Gross WL. Incidence and specificity of p-ANCA in rheumatic diseases. In: Gross WL, editor. ANCA-associated vasculitis: immunological and clinical aspects. London: Plenum; 1993. p. 371-3.
19. Waldendorf M, Schneider M. Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus. In: Gross WL, editor. ANCA-associaled vasculitis: immunological and clinical aspects. London: Plenum; 1993. p. 381-4.
20. Gross WL, Schmitt WH, Csernok E. Antineutrophil cytoplasmic autoantibody-associated diseases: a rheumatologist's perspective. Am J Kidney Dis 1991;18:175-9.
21. Juby A, Johnston C, Davis P, Russell S. Antinuclear and antineutrophil cytoplasmic antibodies (ANCA) in the sera of patients with Felty's syndrome. Br J Rheumatol 1992;31:185-8.
22. Lassoued S, Sixou L, Oksman F, Pages M, Fournie A. Antineutrophil cytoplasmic antibodies and antibodies to myeloperoxidase in rheumatoid arthritis [letter]. Arthritis Rheum 1991;34: 1069-70.
23. Coremans IEM, Hagen EC, Daha MR, van der Woude FJ, van der Voort EAM, Kleijburg-van der Keur C, et al. Antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis. Arthritis Rheum 1992;35:1466-75.
24. Mulder AHL, Horst G, van Leeuwen MA, Limburg PC, Kallenberg CGM. Antineutrophil cytoplasmic antibodies in rheumatoid arthritis: characterization and clinical correlations. Arthritis Rheum 1993;36:1054-60.
25. Röther E, Metzger D, Lang B, Melchers I, Peter HH. Antineutrophil cytoplasm antibodies (ANCA) in rheumatoid arthritis: relationship to HLA-DR phenotypes, rheumatoid factor, antinuclear antibodies and disease severity. Rheumatol Int 1994;14: 155-61.
26. Bosch X, Llena J, Collado A, Font J, Mirapeix E, Ingelmo M, et al. Occurrence of antineutrophil cytoplasmic and antineutrophil (peri)nuclear antibodies in rheumatoid arthritis. J Rheumatol 1995;22:2038-45.
27. Afeltra A, Sebastiani GD, Galeazzi M, Caccavo D, Ferri GM, Marcolongo R, et al. Antineutrophil cytoplasmic antibodies in synovial fluid and in serum of patients with rheumatoid arthritis and other types of synovitis. J Rheumatol 1996;23:10-5.
28. De Bandt M, Meyer O, Haim T, Kahn M-F. Antineutrophil cytoplasmic antibodies in rheumatoid arthritis patients. Br J Rheumatol 1996;35:38-43.
29. Braun MG, Csernok E, Schmitt WH, Gross WL. Incidence, target antigens, and clinical implications of antineutrophil cytoplasmic antibodies in rheumatoid arthritis. J Rheumatol 1996;23:826-30.
30. Mustila A, Korpela M, Mustonen J, Helin H, Huhtala H, Soppi E, et al. Perinuclear antineutrophil cytoplasmic antibody in rheumatoid arthritis: a marker of severe disease with associated nephropathy. Arthritis Rheum 1997;40:710-7.
31. Brimnes J, Halberg P, Jacobsen S, Wiik A, Heegaarg NHH. Specificities of anti-neutrophil autoantibodies in patients with rheumatoid arthritis (RA). Clin Exp Immunol 1997;110:250-6.
32. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
33. Fries JF. Reevaluating the therapeutic approach to rheumatoid arthritis: the "saw tooth" strategy. J Rheumatol 1990;17:12-5.
34. Ritchie DM, Boyle JA, McInnes JM, Jasani MK, Dalakos TG, Grieveson P, et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. QJM 1968;37:393-406.
35. Scott J, Huskisson EC. Graphic presentation of pain. Pain 1976; 2:175-84.
36. Larsen A, Dale K, Eck M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn 1977;18:481-91.
37. Paimela L, Gripenberg M, Kurki P, Leirisalo-Repo M. Antikeratin antibodies: diagnostic and prognostic markers for early rheumatoid arthritis. Ann Rheum Dis 1992;51:743-6.
38. Hoet RMA, Boerbooms AMT, Arends M, Ruiter DJ, van Venrooij WJ. Antiperinuclear factor, a marker autoantibody for rheumatoid arthritis: colocalisalion of the perinuclear factor and profilaggrin. Ann Rheum Dis 1991;50:611-8.
39. Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS 1989;97:12-3.
40. Wiik A. Granulocyte-specific antinuclear antibodies. Allergy 1980; 35:263-89.
41. Von Essen R, Kurki P, Isomäki H, Okubo S, Kautiainen H, Aho K. Prospect for an additional laboratory criterion for rheumatoid arthritis. Scand J Rheumatol 1993;22:267-72.
42. Aho K, Palosuo T, Kurki P. Marker antibodies of rheumatoid arthritis: diagnostic and pathogenetic implications. Semin Arthritis Rheum 1994;23:379-87.
43. Vincent C, de Keyser F, Masson-Bessiere C, Sebbag M, Veys EM, Serre G. Anti-perinuclear factor compared with the so called "antikeratin" antibodies and antibodies to human epidermis filaggrin, in the diagnosis of arthritides. Ann Rheum Dis 1999;58:42-8.
44. Sebbag M, Simon M, Vincent C, Masson-Bessiere C, Girbal E, Durieux J-J, et al. The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. J Clin Invest 1995;95:2672-9.
45. De Carvalho, Graudal H. Radiographic progression of rheumatoid arthritis related to some clinical and laboratory parameters. Acta Radiol Diagn 1980;21:551-5.
46. Aho K, Palosuo T, Lukka M, Kurki P, Isomäki H, Kautiainen H, et al. Antifilaggrin antibodies in recent-onset arthritis. Scand J Rheumatol 1999;28:113-6.
47. Hayem G, Chazerain P, Combe B, Elias A, Haim T, Nicaise P, et al. Anti-Sa antibody is an accurate diagnostic and prognostic marker in adult rheumatoid arthritis. J Rheumatol 1999;26:7-13.